BDNF and Insulin resistance: This is consistent with the loss of spine density and impaired synaptic plasticity and cognition concurrently with reduced BDNF levels due to insulin resistance [70], while improved insulin signaling upregulates BDNF, increases Akt phosphorylation, enhances cognition, and halts neuroinflammation and oxidative stress in Alzheimer’s disease [71,72].